The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ABBVIE INC. COM 00287Y109 85,968 1,580,000 SH   SOLE   1,580,000 0 0
AEGERION PHARMACEUTICALS INC COM 00767E102 34,748 2,555,000 SH   SOLE   2,555,000 0 0
AMGEN INC COM 031162100 12,449 90,000 SH   SOLE   90,000 0 0
ANI PHARMACEUTICALS INC COM 00182C103 1,225 31,000 SH   SOLE   31,000 0 0
APRICUS BIOSCIENCES INC COM 03832V109 9,526 6,524,505 SH   SOLE   6,524,505 0 0
ARIAD PHARMACEUTICALS INC COM 04033A100 75,044 12,850,000 SH   SOLE   12,850,000 0 0
AVEO PHARMACEUTICALS INC COM 053588109 2,800 2,313,759 SH   SOLE   2,313,759 0 0
CATALYST BIOSCIENCES INC. COM 14888D109 419 90,000 SH   SOLE   90,000 0 0
ELEVEN BIOTHERAPEUTICS INC COM 286221106 99 41,200 SH   SOLE   41,200 0 0
ESPERION THERAPEUTICS INC NE COM 29664W105 10,568 448,000 SH   SOLE   448,000 0 0
INTRA CELLULAR THERAPIES INC COM 46116X101 25,626 640,000 SH   SOLE   640,000 0 0
KINDRED BIOSCIENCES INC COM 494577109 3,583 689,091 SH   SOLE   689,091 0 0
MEDICINES CO COM 584688105 59,483 1,567,000 SH   SOLE   1,567,000 0 0
MERCK & CO INC NEW COM 58933Y105 19,756 400,000 SH   SOLE   400,000 0 0
PACIRA PHARMACEUTICALS INC COM 695127100 15,618 380,000 SH   SOLE   380,000 0 0
QUEST DIAGNOSTICS INC COM 74834L100 35,345 575,000 SH   SOLE   575,000 0 0
REPROS THERAPEUTICS INC COM NEW 76028H209 8,413 1,132,367 SH   SOLE   1,132,367 0 0
VIVUS INC COM 928551100 4,221 2,573,943 SH   SOLE   2,573,943 0 0